We are stronger when we are all protected against respiratory diseases,” said Dr. Tomas Aragon, public health officer for ...

Mary Washington Healthcare with information to protect your family from RSV--including infants and older adults.

The rates of respiratory syncytial virus-associated hospitalizations were three to nine times higher for assisted living residents compared with the rates for community-dwelling older adults in a ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

The arrival of cooler weather and people gathering indoors can lead to the increased spread of COVID-19, influenza and ...

Often dismissed as just another common cold, RSV can be deadly, especially for infants and older people. Hannah and her twin ...

The following is a summary of “Respiratory viral infections from 2015 to 2022 in the HIVE cohort of American households: Incidence, illness characteristics, and seasonality,” published in the August ...

GSK has revised its annual vaccine sales forecast following new guidance on RSV from the CDC. But new evidence offers new ...

Bengaluru is witnessing a sharp increase in acute respiratory tract infections among children, attributed to unpredictable ...

A tripledemic refers to the simultaneous surge of three respiratory illnesses: COVID-19, influenza (flu), and respiratory syncytial virus (RSV), which occurred ... new RSV vaccines have been approved ...

GSK (GSK) reached the main goal in a Phase 3 trial for its RSV shot, Arexvy co--administered with Shingles vaccine Shingrix.